Capital International Investors
Institutional investor · Portfolio as of Q4 2018
Top Holdings377 positions
Microsoft Corp. | 92.7M | $9.4B | 4.7% | $94.43 | 0.00% | 1 qtr | First report 0 |
Broadcom Inc | 29.6M | $7.5B | 3.7% | $20.95 | 0.00% | 1 qtr | First report 0 |
Amazon.com, Inc. | 4.6M | $7B | 3.5% | $75.10 | 0.00% | 1 qtr | First report 0 |
INTEL CORP | 110.5M | $5.2B | 2.6% | $40.39 | 0.00% | 1 qtr | First report 0 |
Meta Platforms Inc | 36M | $4.7B | 2.4% | $129.85 | 0.00% | 1 qtr | First report 0 |
UnitedHealth Group Inc. | 17M | $4.2B | 2.1% | $217.84 | 0.00% | 1 qtr | First report 0 |
WELLS FARGO CO NEW | 90.8M | $4.2B | 2.1% | $37.34 | 0.00% | 1 qtr | First report 0 |
COMCAST CORP NEW | 120.5M | $4.1B | 2.0% | $25.39 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc. | 3.9M | $4B | 2.0% | $51.29 | 0.00% | 1 qtr | First report 0 |
ENBRIDGE INC | 106.9M | $3.3B | 1.7% | $19.74 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 25M | $3.2B | 1.6% | $104.33 | 0.00% | 1 qtr | First report 0 |
Coca-Cola Co (The) | 63.6M | $3B | 1.5% | $37.45 | 0.00% | 1 qtr | First report 0 |
Chevron Corp. | 27.3M | $3B | 1.5% | $78.50 | 0.00% | 1 qtr | First report 0 |
CME Group Inc. | 14.9M | $2.8B | 1.4% | $142.48 | 0.00% | 1 qtr | First report 0 |
AbbVie Inc. | 29.6M | $2.7B | 1.4% | $66.47 | 0.00% | 1 qtr | First report 0 |
Merck & Co., Inc | 33.2M | $2.5B | 1.3% | $57.51 | 0.00% | 1 qtr | First report 0 |
Philip Morris International Inc. | 37M | $2.5B | 1.2% | $45.25 | 0.00% | 1 qtr | First report 0 |
EOG Resources Inc. | 28.3M | $2.5B | 1.2% | $64.11 | 0.00% | 1 qtr | First report 0 |
Northrop Grumman Corporation | 10M | $2.5B | 1.2% | $215.69 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co. | 23.8M | $2.3B | 1.2% | $79.10 | 0.00% | 1 qtr | First report 0 |
Capital International Investors manages $200.6B across 377 positions as of Q4 2018. Top holdings: MSFT (4.7%), AVGO (3.7%), AMZN (3.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.
First quarter we have for this fund: 377 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $200.6B across 377 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR